10.1046/j.1365-2125.2003.01907.x 53 SterneJ.HernnM.ReevesB.SavoviJ.BerkmanN.ViswanathanM.et al (2016)
Cellular Effects in Experimental Models Across experimental models, BPC-157 exposure is associated with several measurable cellular responses
It is FDA-approved for several conditions, including pediatric growth hormone deficiency, adult growth hormone deficiency, Turner syndrome, idiopathic short stature, AIDS-associated wasting, and short bowel syndrome, and is sold under brand names including Genotropin, Humatrope, Norditropin, Saizen, and Omnitrope
Lab Tested Supplements You Can Trust Not sure where to start
Tendon, Ligament, and Muscle Injury, Osteotendinous, Myotendinous, and Muscle-to-Bone Junction Therapy Perspectives with Growth Factors and Stable Gastric Pentadecapeptide BPC 157-A Review